(Q82749809)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038563%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

A dose-optimization trial of laronidase (Aldurazyme) in patients with mucopolysaccharidosis I (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038563%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

mucopolysaccharidosis I

1 reference

1

Roberto Giugliani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038563%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Verónica Muñoz Rojas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038563%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ana Maria Martins

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038563%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Eugênia R Valadares

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038563%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Joe T R Clarke

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038563%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

José E C Góes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038563%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Emil D Kakkis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038563%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Mary Alice Worden

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038563%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Marisa Sidman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038563%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Gerald F Cox

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038563%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

26 November 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038563%20AND%20SRC:MED&resulttype=core&format=json

Molecular Genetics and Metabolism

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038563%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038563%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038563%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

13-19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038563%20AND%20SRC:MED&resulttype=core&format=json

The clinical spectrum of alpha-L-iduronidase deficiency

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.10.009

Prevalence of lysosomal storage disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.10.009

The frequency of lysosomal storage diseases in The Netherlands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.10.009

Incidence of inborn errors of metabolism in British Columbia, 1969-1996.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.10.009

The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.10.009

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.10.009

Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.10.009

Enzyme-replacement therapy in mucopolysaccharidosis I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.10.009

Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.10.009

Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.10.009

Overexpression of the human lysosomal enzyme alpha-L-iduronidase in Chinese hamster ovary cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.10.009

Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.10.009

A review and selection of simple laboratory methods used for the study of glycosaminoglycan excretion and the diagnosis of the mucopolysaccharidoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.10.009

Enzyme replacement therapy for the mucopolysaccharide storage disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.10.009

10.1016/J.YMGME.2008.10.009

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038563%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference